{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:07:17Z","timestamp":1776704837044,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.medmal.2020.10.022","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T02:50:26Z","timestamp":1603335026000},"page":"399-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Compassionate use of cefiderocol in a pancreatic abscess and emergence of resistance"],"prefix":"10.1016","volume":"51","author":[{"given":"C.","family":"Grande Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Maillart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.Y.","family":"Miendje Deyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-D.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kamgang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-9686","authenticated-orcid":false,"given":"P.","family":"Clevenbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.medmal.2020.10.022_bib0055","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s10096-017-3063-z","article-title":"Activity of the Novel Siderophore Cephalosporin Cefiderocol Against Multidrug-Resistant Gram-negative Pathogens","volume":"36","author":"Dobias","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2020.10.022_bib0060","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","author":"Wunderink","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.medmal.2020.10.022_bib0065","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1093\/cid\/ciz829","article-title":"Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance","volume":"69","author":"Echols","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2020.10.022_bib0070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01872-19","article-title":"Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-(-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient","volume":"64","author":"Alamarat","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.medmal.2020.10.022_bib0075","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/phar.2334","article-title":"Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report","volume":"39","author":"Stevens","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.medmal.2020.10.022_bib0080","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/cid\/ciy963","article-title":"Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa","volume":"68","author":"Edgeworth","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2020.10.022_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.medmal.2020.10.022_bib0090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jgar.2020.07.009","article-title":"Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from global surveillance program (SIDERO-WT-2014). J Glob","author":"Kohira","year":"2020","journal-title":"Antimicrob Resist"},{"key":"10.1016\/j.medmal.2020.10.022_bib0095","series-title":"Mechanism of Cefiderocol high MIC mutants obtained in non-clinical FoR studies. Poster Abstract Session: Resistance Mechanisms: Gram-Negative. Poster 696. IDSA week 2018","author":"Ito","year":"2018"},{"issue":"12","key":"10.1016\/j.medmal.2020.10.022_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/genes7120126","article-title":"Regulation of Pseudomonas aeruginosa Virulence by Distinct Iron Sources","volume":"7","author":"Reinhart","year":"2016","journal-title":"Genes (Basel)"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X20307629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X20307629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:37:32Z","timestamp":1760078252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X20307629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0399077X20307629"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2020.10.022","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compassionate use of cefiderocol in a pancreatic abscess and emergence of resistance","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2020.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}